IRulya Therapeutics, Inc. (IRLA)
32.95
+1.33
(+4.21%)
USD |
NASDAQ |
Oct 30, 16:00
33.50
+0.55
(+1.67%)
After-Hours: 20:00
IRulya Therapeutics EPS Diluted (Quarterly) : -12.31 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.31 |
| March 31, 2026 | 78.15 |
| December 31, 2025 | -141.62 |
| September 30, 2025 | -49.83 |
| June 30, 2025 | -68.75 |
| March 31, 2025 | -0.342 |
| December 31, 2024 | -56.78 |
| September 30, 2024 | -0.1272 |
| June 30, 2024 | -0.6434 |
| March 31, 2024 | -0.2592 |
| December 31, 2023 | -0.2171 |
| September 30, 2023 | -0.1483 |
| June 30, 2023 | -0.136 |
| March 31, 2023 | -0.3418 |
| December 31, 2022 | -0.1531 |
| September 30, 2022 | -0.2224 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.5102 |
| March 31, 2022 | -0.7182 |
| December 31, 2021 | -0.7812 |
| September 30, 2021 | -0.7292 |
| June 30, 2021 | -0.7352 |
| March 31, 2021 | -0.7811 |
| December 31, 2020 | -0.6958 |
| September 30, 2020 | -0.7293 |
| June 30, 2020 | -0.5982 |
| March 31, 2020 | -0.6078 |
| December 31, 2019 | -0.4607 |
| September 30, 2019 | -0.3673 |
| June 30, 2019 | -0.5718 |
| March 31, 2019 | -0.2116 |
| June 30, 2018 | -23.16 |
| March 31, 2018 | -0.1258 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -2.890 |
| PepGen Inc. | -0.2574 |
| Q32 Bio, Inc. | -0.4398 |
| Bridgebio Oncology Therapeutics, Inc. | -705.20 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -75.49M |
| Total Expenses (Quarterly) | 75.49M |
| Enterprise Value | 61.34M |
| Earnings Yield | -381.2% |
| Normalized Earnings Yield | -367.58 |